子类别 期刊論文 [328/331] 圖書 [1/1] 會議論文/會議摘要 [115/179] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [104/107] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [67/72] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [465/472] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:75(14.68%) 含全文笔数:444(86.89%) 文件下载次数统计 下载大于0次:444(100.00%) 下载大于100次:426(95.95%) 全文下载总次数:178521(3.33%) 最后更新时间: 2024-12-03 08:59 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Cooperative participation of CagA a... Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura... Durvalumab or placebo plus gemcitab... Impact of previous S-1 treatment on...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目326-350 / 511. (共21页) << < 9 10 11 12 13 14 15 16 17 18 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2014-05	A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617.
2014-03	Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma	APMIS. 2014 Mar;122(3):206-214.
2014-02	RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated notch1 activation	Journal of Cellular Physiology. 2014 Feb;229(2):191-201.
2014-02	BCL6 overexpression is associated with decreased p19ARF expression and confers an independent prognosticator in gallbladder carcinoma	Tumor Biology. 2014 Feb;35(2):1417-1426.
2014-02	Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse	Genes Chromosomes and Cancer. 2014 Feb;53(2):211-213.
2014-02	The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: A nation-wide cancer registry-based study	BMC Cancer. 2014 Feb 18;14:Article number 102.
2014-01	EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl.):Abstract number 172
2014-01	Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial	Journal of Clinical Oncology. 2014 Jan;32(3 Suppl):Abstract number 267.
2013-12-31	Second cancers in patients with neuroendocrine tumors	PLoS ONE. 2013 Dec 31;8(12):Article number e86414.
2013-12	Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma	Tumor Biology. 2013 Dec;34(6):3923-3931.
2013-12	Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma	Journal of Hepatology. 2013 Dec;59(6):1271-1277.
2013-12	Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient	Kaohsiung Journal of Medical Sciences. 2013 Dec;29(12):691-694.
2013-11	A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression	Gastroenterology. 2013 Nov;145(5):1110-1120.
2013-11	Management of gastric cancer in Asia: Resource-stratified guidelines	Lancet Oncology. 2013 Nov;14(12):e535-e547.
2013-10	Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification	Biochemical Pharmacology. 2013 Oct;86(7):872-887.
2013-10	Clinicopathological significance of HuR expression in gallbladder carcinoma: With special emphasis on the implications of its nuclear and cytoplasmic expression	Tumor Biology. 2013 Oct;34(5):3059-3069.
2013-08	A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer	British Journal of Cancer. 2013 Aug;109(4):920-925.
2013-07-23	IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder	Journal of Clinical Pathology. 2013 Jul 23;66(7):573-582.
2013-07-22	Medical risk factors associated with cholangiocarcinoma in taiwan: A population-based case-control study	PLoS ONE. 2013 Jul 22;8(7):Article number e69981.
2013-07	Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance	Blood Cancer Journal. 2013 Jul;3:Article number e125.
2013-06-21	A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma	Annals of Oncology. 2013 Jun 21;24(6):1567-1573.
2013-06-20	Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations	PLoS ONE. 2013 Jun 20;8(6):Article number e65762.
2013-06	No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply	Genes Chromosomes and Cancer. 2013 Jun;52(6):593-594.
2013-06	ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: Aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance	Clinical Cancer Research. 2013 Jun;19:2861-2872.
2013-05	Loss of epithelial membrane protein-2 expression confers an independent prognosticator in gallbladder carcinoma	Biomarkers and Genomic Medicine. 2013 May;5(1-2):31-38.

显示项目326-350 / 511. (共21页) << < 9 10 11 12 13 14 15 16 17 18 > >> 每页显示[10|25|50]项目